Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Biora Therapeutics, Inc. (BIORQ)

Aptevo Therapeutics Inc. and Biora Therapeutics, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and Biora Therapeutics, Inc. are of similar size ($2.5M and $2.3M). Biora Therapeutics, Inc. grew revenue faster over the last twelve months: 347.0% against 92.9%. Aptevo Therapeutics Inc. has the higher net margin (0.00% vs −3,527.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Biora Therapeutics, Inc. leads on 8 and Aptevo Therapeutics Inc. on 7.

Valuation

Metric APVO BIORQ Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 n/m 9.40
P/B 0.25 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 n/m 0.66
EV/Sales (0.37) 67.44 9.02
Earnings yield (4,659.10%) 0.00% (32.88%)
Free cash flow yield (1,718.19%) 0.00% (23.13%)

Profitability

Metric APVO BIORQ Biotechnology median
Gross margin 0.00% 85.79% 68.51%
Operating margin 0.00% (6,809.06%) 0.00%
Net margin 0.00% (3,527.85%) 0.00%
Free cash flow margin 0.00% (5,165.88%) 0.00%
Return on equity (446.89%) 27.98% (51.96%)
Return on assets (186.29%) (128.19%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO BIORQ Biotechnology median
Revenue growth (TTM) 92.94% 347.00% 6.76%
EPS growth (last fiscal year) 99.72% (57.40%) 29.88%
Revenue growth, 5-year CAGR (26.64%) (87.44%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO BIORQ Biotechnology median
Debt to equity 0.00 (0.18) 0.00
Current ratio 2.08 0.05 4.97
Net debt to EBITDA 0.83 (0.47) 1.01

Dividend

Metric APVO BIORQ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APVO BIORQ Biotechnology median
Market cap 2.30m 2.49m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack